DLBS1033 for the Treatment of Acute Ischemic Stroke

NCT02362984 · clinicaltrials.gov ↗

PHASE3

Phase

TERMINATED

Status

9

Enrollment

INDUSTRY

Sponsor class

Stopped Major technical hindrance in recruitment.

Conditions

Acute Ischemic Stroke

Interventions

DRUG: Placebo
DRUG: DLBS1033

Sponsor

Dexa Medica Group